Combination of aloe emodin, emodin, and rhein from Aloe with EDTA sensitizes the resistant Acinetobacter baumannii to polymyxins

• Published in: Frontiers in cellular and infection microbiology 2024-09, Vol.14, p.1467607
• Main Authors: Zhao, Yue, Zhang, Tingting, Liang, Yinping, Xie, Xiaoqing, Pan, Hongwei, Cao, Meng, Wang, Shuhua, Wu, Dalei, Wang, Jing, Wang, Chuandong, Hu, Wei
• Format: Article
• Language: English
• Subjects: Acinetobacter baumannii; Acinetobacter baumannii - drug effects; Acinetobacter Infections - drug therapy; Acinetobacter Infections - microbiology; Aloe; Aloe - chemistry; Animals; anthraquinone components; Anthraquinones - pharmacology; Anthraquinones - therapeutic use; Anti-Bacterial Agents - pharmacology; Cell Line; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Edetic Acid - pharmacology; Emodin - pharmacology; Emodin - therapeutic use; ethylenediaminetetraacetic acid; Humans; Mice; Microbial Sensitivity Tests; Polymyxins - pharmacology; Polymyxins - therapeutic use; polymyxins resistance
• ISSN: 2235-2988; 2235-2988
• DOI: 10.3389/fcimb.2024.1467607

The continuous emergence and spread of polymyxin-resistant pose a significant global health challenge, necessitating the development of novel therapeutic strategies. Aloe, with its long-standing history of medicinal use, has recently been the subject of substantial research for its efficacy against pathogenic infections. This study investigates the potential application of anthraquinone components in aloe against polymyxin-resistant by liquid chromatography-mass spectrometry, in vitro activity assessment, and construction of animal infection models. The findings demonstrate that aloe emodin, emodin, rhein, and their mixtures in equal mass ratios (EAR) exhibit strain-specific antibacterial activities against polymyxin-resistant . Co-administration of EAR with EDTA synergistically and universally enhanced the antibacterial activity and bactericidal efficacy of polymyxins against polymyxin-resistant , while also reducing the frequency of polymyxin-resistant mutations in polymyxinssensitive . Following toxicity assessment on human hepatic and renal cell lines, the combination therapy was applied to skin wounds in mice infected with polymyxin-resistant . Compared to monotherapy, the combination therapy significantly accelerated wound healing and reduced bacterial burden. The combination of EAR and EDTA with polymyxins offers a novel therapeutic approach for managing skin infections caused by polymyxinresistant .